1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 05144164 2024-01-01 2024-12-31 05144164 2024-12-31 05144164 2023-12-31 05144164 2023-01-01 2023-12-31 05144164 2023-12-31 05144164 2022-12-31 05144164 bus:Director1 2024-01-01 2024-12-31 05144164 core:WithinOneYear 2024-12-31 05144164 core:WithinOneYear 2023-12-31 05144164 core:AfterOneYear 2024-12-31 05144164 core:AfterOneYear 2023-12-31 05144164 bus:Micro-entities 2024-01-01 2024-12-31 05144164 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 05144164 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05144164 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05144164 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 05144164
PHARMAPRICE INTERNATIONAL LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 December 2024
PHARMAPRICE INTERNATIONAL LIMITED
BALANCE SHEET
31 December 2024
2024
2023
£
£
£
Fixed assets
628
94
----
----
Current assets
33,197
56,618
Prepayments and accrued income
12,309
14,619
--------
--------
45,506
71,237
Creditors: amounts falling due within one year
24,805
41,143
--------
--------
Net current assets
20,701
30,094
--------
--------
Total assets less current liabilities
21,329
30,188
Creditors: amounts falling due after more than one year
2,868
6,969
Accruals and deferred income
18,436
23,011
--------
--------
25
208
--------
--------
Capital and reserves
25
208
----
----
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
2. Director's advances, credits and guarantees
During the year a loan advance was made to the director of £4,141. No interest was charged. Repayment was made on 31 March 2025.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 26 September 2025 , and are signed on behalf of the board by:
A B Barak
Director
Company registration number: 05144164
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 The Chambers, Vineyard, Abingdon-on-Thames.